Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129256) titled 'Application of Plasma ctDNA Methylation Markers in Recurrence Detection and Prognostic Assessment Following Local Ablation for Non-Small Cell Lung Cancer' on Aug. 2.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: West China School of Medicine/West China Hospital, Sichuan University
Condition:
lung cancer
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-03
Target Sample Size: observation group:150;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=325770
Published by HT Digital Content Services with ...